Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $103.0600 (-1.7%) ($103.0500 - $105.3300) on Wed. Mar. 24, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.58% (three month average) | RSI | 46 | Latest Price | $103.0600(-1.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.4% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(45%) SPLV(36%) VYM(32%) XLP(32%) DIA(30%) | Factors Impacting ABBV price | ABBV will decline at least -0.79% in a week (0% probabilities). VIXM(-21%) UUP(-10%) VXX(-3%) TLT(-1%) KWEB(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.79% (StdDev 1.58%) | Hourly BBV | -1.8 () | Intraday Trend | -1.7% | | | |
|
Inflection Point | Yes | Resistance Level | $106.67 | 5 Day Moving Average | $104.2(-1.09%) | 10 Day Moving Average | $106.2(-2.96%) | 20 Day Moving Average | $106.67(-3.38%) | To recent high | -8.5% | To recent low | 0.7% | Market Cap | $181.827b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |